203 related articles for article (PubMed ID: 30127221)
1. Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation.
Huang WR; Liu DH
Chin Med J (Engl); 2018 Sep; 131(17):2105-2111. PubMed ID: 30127221
[TBL] [Abstract][Full Text] [Related]
2. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.
Corradini P; Dodero A; Zallio F; Caracciolo D; Casini M; Bregni M; Narni F; Patriarca F; Boccadoro M; Benedetti F; Rambaldi A; Gianni AM; Tarella C
J Clin Oncol; 2004 Jun; 22(11):2172-6. PubMed ID: 15169805
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG
Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369
[TBL] [Abstract][Full Text] [Related]
4. [Clinical Study of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Peripheral T-Cell Lymphoma].
Xue S; Zhangliu FH; Zhang YP; Li TT; Liu YY; Wang JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1973-1978. PubMed ID: 31839069
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Allogeneic Stem Cell Transplant and Autologous Stem Cell Transplant in Refractory or Relapsed Peripheral T-Cell Lymphoma: A Systematic Review and Meta-analysis.
Du J; Yu D; Han X; Zhu L; Huang Z
JAMA Netw Open; 2021 May; 4(5):e219807. PubMed ID: 34042995
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of myeloablative peripheral blood stem cell transplantation for non-complete remission patients with relapsed/refractory peripheral T cell lymphomas.
Gu Z; Wang L; Wang Q; Li H; Bo J; Wang S; Zhao Y; Li F; Gao C; Liu D; Huang W
Ann Hematol; 2019 May; 98(5):1237-1247. PubMed ID: 30539277
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.
Dodero A; Spina F; Narni F; Patriarca F; Cavattoni I; Benedetti F; Ciceri F; Baronciani D; Scimè R; Pogliani E; Rambaldi A; Bonifazi F; Dalto S; Bruno B; Corradini P
Leukemia; 2012 Mar; 26(3):520-6. PubMed ID: 21904377
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of clinical outcomes of allogeneic hematopoietic stem cell transplantation for relapsed/refractory peripheral T-cell lymphoma with chemoresistance].
Wang L; Li NN; Wang Z; Wu XX; Dong YJ; Fu XR; Liu Y; Hu LD; Li XF; Wang YN; Wu YM; Ren HY; Zhang MZ; Wang MH; Li YH; Liu DH; Huang WR
Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3786-3791. PubMed ID: 31874515
[No Abstract] [Full Text] [Related]
9. [Comparison of allogeneic or autologous hematopoietic stem cell transplant for high-risk peripheral T cell lymphomas].
Wang QL; Huang HW; Jin ZM; Tang XW; Qiu HY; Fu CC; Han Y; Miao M; Chang HR; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):952-956. PubMed ID: 27995879
[TBL] [Abstract][Full Text] [Related]
10. [Second allogeneic transplant for leukemia relapsed after first allogeneic transplantation].
Yang DL; Han MZ; Feng SZ; Wang M; Zou DH; Wei JL; Yan ZS; Zhou SY; Liu QG; Jiang EL; Huang Y; Wang HH; Zhou Z; Zhai WJ; Yan WW; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):285-9. PubMed ID: 15182537
[TBL] [Abstract][Full Text] [Related]
11. Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center.
Loirat M; Chevallier P; Leux C; Moreau A; Bossard C; Guillaume T; Gastinne T; Delaunay J; Blin N; Mahé B; Dubruille V; Augeul-Meunier K; Peterlin P; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Mohty M; Moreau P; Le Gouill S
Ann Oncol; 2015 Feb; 26(2):386-92. PubMed ID: 25392158
[TBL] [Abstract][Full Text] [Related]
12. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP
Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271
[TBL] [Abstract][Full Text] [Related]
13. [Salvage Trerapy for Patients with Relapsed and Refractory Lymphoma by Allogeneic Hematopoietic Stem Cell Transplantation].
Yin Y; Qiu ZX; Li Y; Xu WL; Sun YH; Liu W; Wang WS; Wang MJ; Wang LH; Dong YJ; Ou JP; Cen XN; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):418-425. PubMed ID: 28446286
[TBL] [Abstract][Full Text] [Related]
14. Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case.
Weiner DM; Lewis DJ; Spaccarelli NG; Clark RA; Nasta SD; Loren AW; Rook AH; Kim EJ
Dermatol Ther; 2022 Jul; 35(7):e15538. PubMed ID: 35477952
[TBL] [Abstract][Full Text] [Related]
15. A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China.
Gu ZY; Dong YJ; Fu XR; Li NN; Liu Y; Wu XX; Wang YN; Li YH; Ren HY; Zhang MZ; Li XF; Wang MH; Wu YM; Liu DH; Wang Z; Hu LD; Huang WR
Chin Med J (Engl); 2021 Jun; 134(13):1584-1592. PubMed ID: 34133361
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.
Berning P; Schmitz N; Ngoya M; Finel H; Boumendil A; Wang F; Huang XJ; Hermine O; Philippe L; Couronné L; Jaccard A; Liu D; Wu D; Reinhardt HC; Chalandon Y; Wagner-Drouet E; Kwon M; Zhang X; Carpenter B; Yakoub-Agha I; Wulf G; López-Jiménez J; Sanz J; Labussière-Wallet H; Shimoni A; Dreger P; Sureda A; Kim WS; Glass B
Leukemia; 2023 Jul; 37(7):1511-1520. PubMed ID: 37157017
[TBL] [Abstract][Full Text] [Related]
17. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
Shustov A
Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
[TBL] [Abstract][Full Text] [Related]
18. Myeloablative Haploidentical Transplant as an Alternative to Matched Sibling Transplant for Peripheral T-Cell Lymphomas.
Zhenyang G; Nainong L; Xiaoxiong W; Maihong W; Xiaorui F; Zhao W; Hanyun R; Yuhang L; Xiaofan L; Yamei W; Yao L; Mingzhi Z; Yini W; Daihong L; Yujun D; Liangding H; Wenrong H
Cell Transplant; 2021; 30():963689721999615. PubMed ID: 33745341
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.
Peng YY; Xiong YY; Zhang LX; Wang J; Zhang HB; Xiao Q; Guo SL
Turk J Haematol; 2021 Jun; 38(2):126-137. PubMed ID: 33535731
[TBL] [Abstract][Full Text] [Related]
20. [Treatment approach for relapse of adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation].
Kato K
Rinsho Ketsueki; 2021; 62(5):505-511. PubMed ID: 34248128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
